{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:49:49Z","timestamp":1786121389955,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.humpath.2026.106172","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T16:27:11Z","timestamp":1779899231000},"page":"106172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Revisiting nuclear grade as a high-risk marker for predicting upgrade in ductal carcinoma in situ"],"prefix":"10.1016","volume":"175","author":[{"given":"Yuko","family":"Ueki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8935-0768","authenticated-orcid":false,"given":"Yoshiya","family":"Horimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuharu","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1588-3067","authenticated-orcid":false,"given":"Yumiko","family":"Ushiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Nozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Ishizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8670-4357","authenticated-orcid":false,"given":"Ryoko","family":"Semba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuki","family":"Uenaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Kawate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5946-3742","authenticated-orcid":false,"given":"Takeshi","family":"Ushigusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Onagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8544-9370","authenticated-orcid":false,"given":"Takuo","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goro","family":"Kutomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3450-4533","authenticated-orcid":false,"given":"Takashi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3441-7739","authenticated-orcid":false,"given":"Rin","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2026.106172_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41523-021-00364-z","article-title":"Ductal carcinoma in situ: a risk prediction model for the underestimation of invasive breast cancer","volume":"8","author":"Park","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.humpath.2026.106172_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1148\/radiol.11102368","article-title":"Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer","volume":"260","author":"Brennan","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.humpath.2026.106172_bib3","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1016\/j.jss.2009.07.030","article-title":"Significance of HER2 protein examination in ductal carcinoma in situ","volume":"167","author":"Horimoto","year":"2011","journal-title":"J Surg Res"},{"key":"10.1016\/j.humpath.2026.106172_bib4","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.breast.2012.06.012","article-title":"Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision","volume":"21","author":"Kim","year":"2012","journal-title":"Breast"},{"key":"10.1016\/j.humpath.2026.106172_bib5","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1245\/s10434-017-5927-y","article-title":"A validated nomogram to predict upstaging of ductal carcinoma in situ to invasive disease","volume":"24","author":"Jakub","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.humpath.2026.106172_bib6","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s12282-021-01225-0","article-title":"Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study","volume":"28","author":"Tanaka","year":"2021","journal-title":"Breast Cancer"},{"key":"10.1016\/j.humpath.2026.106172_bib7","doi-asserted-by":"crossref","first-page":"7505","DOI":"10.1038\/s41598-025-92080-y","article-title":"Integrating radiomics into predictive models for low nuclear grade DCIS using machine learning","volume":"15","author":"Wu","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.humpath.2026.106172_bib8","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/s41416-018-0276-6","article-title":"A prediction model for underestimation of invasive breast cancer after a biopsy diagnosis of ductal carcinoma in situ: based on 2892 biopsies and 589 invasive cancers","volume":"119","author":"Meurs","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2026.106172_bib9","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/jama.2024.26698","article-title":"Active monitoring with or without endocrine therapy for low-risk ductal carcinoma in situ: the COMET randomized clinical trial","volume":"333","author":"Hwang","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.humpath.2026.106172_bib10","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1245\/s10434-016-5595-3","article-title":"Women with low-risk DCIS eligible for the LORIS trial after complete surgical excision: how low is their risk after standard therapy?","volume":"23","author":"Pilewskie","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.humpath.2026.106172_bib11","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","article-title":"Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - the LORD study","volume":"51","author":"Elshof","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.humpath.2026.106172_bib12","series-title":"Breast tumours, WHO classification of tumours","first-page":"75","article-title":"Ductal carcinoma in situ","author":"Fox","year":"2019"},{"key":"10.1016\/j.humpath.2026.106172_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s12282-023-01518-6","article-title":"The Japanese breast cancer society clinical practice guidelines for pathological diagnosis of breast cancer, 2022 edition","volume":"31","author":"Honma","year":"2024","journal-title":"Breast Cancer"},{"key":"10.1016\/j.humpath.2026.106172_bib14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","article-title":"Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up","volume":"19","author":"Elston","year":"1991","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2026.106172_bib15","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","article-title":"Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update","volume":"31","author":"Wolff","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2026.106172_bib16","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/jnci\/djaa201","article-title":"Assessment of Ki67 in breast cancer: updated recommendations from the international Ki67 in Breast Cancer Working Group","volume":"113","author":"Nielsen","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2026.106172_bib17","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/S0140-6736(95)90982-6","article-title":"Prognostic classification of breast ductal carcinoma-in-situ","volume":"345","author":"Poller","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.humpath.2026.106172_bib18","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/bjs.4051","article-title":"Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery","volume":"90","author":"Boland","year":"2003","journal-title":"Br J Surg"},{"key":"10.1016\/j.humpath.2026.106172_bib19","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/jnci\/djy220","article-title":"Cancer outcomes in DCIS patients without locoregional treatment","volume":"111","author":"Ryser","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2026.106172_bib20","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1158\/1078-0432.CCR-18-0201","article-title":"Clinicopathological risk factors for an invasive breast cancer recurrence after ductal carcinoma in situ\u2014A nested case\u2013control study","volume":"24","author":"Visser","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2026.106172_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijrobp.2022.06.072","article-title":"A novel biosignature identifies patients with DCIS with high risk of local recurrence after breast conserving surgery and radiation therapy","volume":"115","author":"Vicini","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.humpath.2026.106172_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153283","article-title":"High EZH2 expression in ductal carcinoma in situ diagnosed on breast core needle biopsy is an independent predictive factor for upgrade on surgical excision","volume":"216","author":"Genco","year":"2020","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.humpath.2026.106172_bib23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12880-020-00494-z","article-title":"The role of MRI and clinicopathologic features in predicting the invasive component of biopsy-confirmed ductal carcinoma in situ","volume":"20","author":"Yoon","year":"2020","journal-title":"BMC Med Imag"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726001413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726001413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T04:29:14Z","timestamp":1786076954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817726001413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":23,"alternative-id":["S0046817726001413"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106172","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revisiting nuclear grade as a high-risk marker for predicting upgrade in ductal carcinoma in situ","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106172","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106172"}}